Ok then, let's 'assume' 4.00 then. Will they use the deal with BK as part of the valuation and will they use the deal currently being worked on with China as part of the valuation?
With potential revenue of 1 billion with BK and 1.5 billion with China, does that figure into the valuation at all?
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links